Literature DB >> 25049231

DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells.

Pei-Pei Zhang1, Xiang-Ling Wang1, Wei Zhao2, Bing Qi1, Qian Yang1, Hai-Ying Wan1, Ze-Yu Shuang3, Min Liu1, Xin Li1, Shengping Li4, Hua Tang5.   

Abstract

MicroRNAs (miRNAs) have been shown to play important roles in carcinogenesis. However, their underlying mechanisms of action in hepatocellular carcinoma (HCC) are poorly understood. Recent evidence suggests that epigenetic silencing of miRNAs through tumor suppression by CpG island hypermethylation may be a common hallmark of human tumors. Here, we demonstrated that miR-941 was significantly down-regulated in HCC tissues and cell lines and was generally hypermethylated in HCC. The overexpression of miR-941 suppressed in vitro cell proliferation, migration, and invasion and inhibited the metastasis of HCC cells in vivo. Furthermore, the histone demethylase KDM6B (lysine (K)-specific demethylase 6B) was identified as a direct target of miR-941 and was negatively regulated by miR-941. The ectopic expression of KDM6B abrogated the phenotypic changes induced by miR-941 in HCC cells. We demonstrated that miR-941 and KDM6B regulated the epithelial-mesenchymal transition process and affected cell migratory/invasive properties.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA Methylation; Epigenetics; Epithelial-Mesenchymal Transition (EMT); Hepatocellular Carcinoma; Invasion; KDM6B; Migration; Proliferation; miR-941; miRNAs

Mesh:

Substances:

Year:  2014        PMID: 25049231      PMCID: PMC4148894          DOI: 10.1074/jbc.M114.567818

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.

Authors:  Kenichi Yamane; Keisuke Tateishi; Robert J Klose; Jia Fang; Laura A Fabrizio; Hediye Erdjument-Bromage; Joyce Taylor-Papadimitriou; Paul Tempst; Yi Zhang
Journal:  Mol Cell       Date:  2007-03-15       Impact factor: 17.970

2.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.

Authors:  Karl Agger; Paul A C Cloos; Jesper Christensen; Diego Pasini; Simon Rose; Juri Rappsilber; Irina Issaeva; Eli Canaani; Anna Elisabetta Salcini; Kristian Helin
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

3.  MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.

Authors:  J-P Zhang; C Zeng; L Xu; J Gong; J-H Fang; S-M Zhuang
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

4.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

5.  The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma.

Authors:  J A Anderton; S Bose; M Vockerodt; K Vrzalikova; W Wei; M Kuo; K Helin; J Christensen; M Rowe; P G Murray; C B Woodman
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

6.  KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.

Authors:  Fábio Pereira; Antonio Barbáchano; Javier Silva; Félix Bonilla; Moray J Campbell; Alberto Muñoz; María Jesús Larriba
Journal:  Hum Mol Genet       Date:  2011-09-02       Impact factor: 6.150

7.  Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

Authors:  Marta Barradas; Emma Anderton; Juan Carlos Acosta; Side Li; Ana Banito; Marc Rodriguez-Niedenführ; Goedele Maertens; Michaela Banck; Ming-Ming Zhou; Martin J Walsh; Gordon Peters; Jesús Gil
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

8.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.

Authors:  Sunhwa Hong; Young-Wook Cho; Li-Rong Yu; Hong Yu; Timothy D Veenstra; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

Review 9.  MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).

Authors:  Xiang-Ming Ding
Journal:  Chin J Cancer       Date:  2013-09-09

10.  DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.

Authors:  George S Watts; Bernard W Futscher; Nicholas Holtan; Koen Degeest; Frederick E Domann; Stephen L Rose
Journal:  BMC Med Genomics       Date:  2008-09-30       Impact factor: 3.063

View more
  19 in total

1.  Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer.

Authors:  X-L Lai; Y-H Huang; Y-S Li; G-N Li; L-P Wang; R Sun; Y-S Ma; S-Y Feng; Z-Y Chang; X-H Wang; D Fu; X Han; X-L Cong; W-P Li
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

2.  Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.

Authors:  Chang Liu; Jinghua Wang; Yang Hu; Hong Xie; Min Liu; Hua Tang
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

3.  Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.

Authors:  Renshun Yuan; Qiaoming Zhi; Hong Zhao; Ye Han; Ling Gao; Bin Wang; Zhongyang Kou; Zhaoji Guo; Songbing He; Xiaofeng Xue; Hao Hu
Journal:  Tumour Biol       Date:  2014-12-16

4.  LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.

Authors:  Wei Zhai; Yin Sun; Changcheng Guo; Guanghui Hu; Mingchao Wang; Jiayi Zheng; WanYing Lin; Qingbo Huang; Gonghui Li; Junhua Zheng; Chawnshang Chang
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

5.  S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation.

Authors:  Madalena Barroso; Derrick Kao; Henk J Blom; Isabel Tavares de Almeida; Rita Castro; Joseph Loscalzo; Diane E Handy
Journal:  Biochim Biophys Acta       Date:  2015-10-24

6.  miR-639 Expression Is Silenced by DNMT3A-Mediated Hypermethylation and Functions as a Tumor Suppressor in Liver Cancer Cells.

Authors:  Jing Xiao; Yankun Liu; Fuxia Wu; Ruiyan Liu; Yongli Xie; Qian Yang; Yufeng Li; Min Liu; Shengping Li; Hua Tang
Journal:  Mol Ther       Date:  2019-11-28       Impact factor: 11.454

7.  Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.

Authors:  Zhangang Xiao; Jing Shen; Lin Zhang; Mingxing Li; Wei Hu; Chihin Cho
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

8.  miR-941 as a promising biomarker for acute coronary syndrome.

Authors:  Ruina Bai; Qiaoning Yang; Ruixi Xi; Lizhi Li; Dazhuo Shi; Keji Chen
Journal:  BMC Cardiovasc Disord       Date:  2017-08-22       Impact factor: 2.298

9.  MicroRNA-941 Expression in Polymorphonuclear Granulocytes Is Not Related to Granulomatosis with Polyangiitis.

Authors:  Jesper Brink Svendsen; Bo Baslund; Elisabeth Præstekjær Cramer; Nicolas Rapin; Niels Borregaard; Jack Bernard Cowland
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

10.  Recently Evolved Tumor Suppressor Transcript TP73-AS1 Functions as Sponge of Human-Specific miR-941.

Authors:  Haiyang Hu; Jian-Mei Liu; Zhenyu Hu; Xi Jiang; Xiaode Yang; Jiangxia Li; Yao Zhang; Haijing Yu; Philipp Khaitovich
Journal:  Mol Biol Evol       Date:  2018-05-01       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.